{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:21:37Z","timestamp":1787775697517,"version":"build-2784847793"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["32\/2010"],"award-info":[{"award-number":["32\/2010"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ijantimicag.2017.06.007","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T20:02:00Z","timestamp":1498680120000},"page":"159-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Amiodarone and itraconazole improve the activity of pentavalent antimonial in the treatment of experimental cutaneous leishmaniasis"],"prefix":"10.1016","volume":"50","author":[{"given":"La\u00eds","family":"Anversa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9232-3031","authenticated-orcid":false,"given":"Monique Gomes","family":"Salles Tiburcio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara Rocha","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00edlia Beatriz","family":"Cuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Antonio","family":"Nogueira Nascentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00e1bata Yamasaki","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virg\u00ednia Bodel\u00e3o","family":"Richini Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana da Silva","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valdo Jos\u00e9","family":"Dias da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Eduardo","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis Worldwide and Global Estimates of Its Incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0015","series-title":"Topley and Wilson's microbiology and microbial infections","first-page":"313","article-title":"New World Leishmaniasis\u2014the neotropical Leishmania species","author":"Lainson","year":"2005"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0020","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1590\/S0074-02762009000700001","article-title":"Proven and putative vectores of American cutaneous leishmaniasis in Brazil: aspects of their biology and vectorial competence","volume":"104","author":"Rangel","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0025","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/0035-9203(93)90030-T","article-title":"The clinical and immunological spectrum of American cutaneous leishmaniasis","volume":"87","author":"Convit","year":"1993","journal-title":"Trans Roy Soc Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0030","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/pgmj.2006.047340","article-title":"Leishmaniasis","volume":"82","author":"Piscopo","year":"2006","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0035","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2174\/1381612023396258","article-title":"Chemotherapy of leishmaniasis","volume":"8","author":"Croft","year":"2002","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0040","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0050","doi-asserted-by":"crossref","first-page":"e709","DOI":"10.1371\/journal.pntd.0000709","article-title":"Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial","volume":"4","author":"Hailu","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0055","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1517\/14728214.2012.748036","article-title":"Liposomal amphotericin B as a treatment for human leishmaniasis","volume":"17","author":"Balasegaram","year":"2012","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0060","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cis474","article-title":"Efficacy of miltefosine in the treatment of visceral Leishmaniasis in India after a decade of use","volume":"55","author":"Sundar","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0065","doi-asserted-by":"crossref","first-page":"28831","DOI":"10.1074\/jbc.M303300200","article-title":"Antifungal activity of amiodarone is mediated by disruption of calcium homeostasis","volume":"278","author":"Gupta","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0070","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1124\/jpet.300.1.195","article-title":"Characterization of a novel, broad-based fungicidal activity for the antiarrythmic drug amiodarone","volume":"300","author":"Courchesne","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0075","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1021\/jm050691f","article-title":"Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole","volume":"49","author":"Benaim","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0080","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1128\/AAC.00505-09","article-title":"Amiodarone and miltefosine act synergistically against Leishmania mexicana and can induce parasitological cure in a murine model of cutaneous leishmaniasis","volume":"53","author":"Serrano-Mart\u00edn","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0085","first-page":"471","article-title":"Targeting calcium homeostasis as the therapy of Chagas' disease and leishmaniasis\u2014a review","volume":"28","author":"Benaim","year":"2011","journal-title":"Trop Biomed"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0090","first-page":"ID642502","article-title":"Sterol biosynthesis pathway as target for anti-trypanosomatid drugs","author":"De Souza","year":"2009","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0095","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.protis.2007.05.004","article-title":"Sterol methenyl transferase inhibitors alter the ultrastructure and function of the Leishmania amazonensis mitochondrion leading to potent growth inhibition","volume":"158","author":"Rodrigues","year":"2007","journal-title":"Protist"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1201-9712(00)90077-8","article-title":"Use of itraconazole in the treatment of mucocutaneous leishmaniasis: a pilot study","volume":"4","author":"Amato","year":"2000","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0105","first-page":"713","article-title":"Comparison of oral itraconazole and intramuscular meglumine antimoniate in the treatment of cutaneous leishmaniasis","volume":"17","author":"Saleem","year":"2007","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0110","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(10)62050-8","article-title":"Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial","volume":"377","author":"Sundar","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0115","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1128\/AAC.43.1.172","article-title":"Experimental evaluation of second-line oral treatments of visceral leishmaniasis caused by Leishmania infantum","volume":"43","author":"Gangneux","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0120","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1128\/JCM.40.5.1666-1669.2002","article-title":"Real-time PCR for detection and quantitation of leishmania in mouse tissues","volume":"40","author":"Nicolas","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083247","article-title":"In vitro activity of the antifungal azoles itraconazole and posaconazole against Leishmania amazonensis","volume":"8","author":"De Macedo-Silva","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0130","first-page":"ID876021","article-title":"Antiproliferative, ultrastructural, and physiological effects of amiodarone on promastigote and amastigote forms of Leishmania amazonensis","author":"De Macedo-Silva","year":"2011","journal-title":"Mol Biol Int"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0135","series-title":"Microbiologia","author":"Trabulsi","year":"2004"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0140","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/00034983.2000.11813603","article-title":"Effects of itraconazole and terbinafine on Leishmania major lesions in BALB\/c mice","volume":"94","author":"Zakai","year":"2000","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0145","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7705\/biomedica.v24i4.1289","article-title":"Efficacy and toxicity of pentavalent antimonials (Glucantime and Pentostam) in an American cutaneous leishmaniasis animal model: luminometry application","volume":"24","author":"Henao","year":"2004","journal-title":"Biomedica"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0150","first-page":"81","article-title":"Animal models for infectious diseases caused by parasites: leishmaniasis","volume":"1","author":"Oliveira","year":"2004","journal-title":"Drug Discovery Today: Disease Models"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0155","doi-asserted-by":"crossref","first-page":"e0003889","DOI":"10.1371\/journal.pntd.0003889","article-title":"A review: the current in vivo models for the discovery and utility of new anti-leishmanial drugs targeting cutaneous leishmaniasis","volume":"9","author":"Mears","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0160","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1590\/S0037-86822007000600005","article-title":"The activity of azithromycin against Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis in the golden hamster model","volume":"40","author":"Sinagra","year":"2007","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0165","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/jac\/dkt318","article-title":"In vitro interaction between paromomycin sulphate and four drugs with leishmanicidal activity against three New World Leishmania species","volume":"69","author":"De Morais-Teixeira","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0170","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","article-title":"Combination therapy for visceral leishmaniasis","volume":"10","author":"Van Griensven","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0175","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4269\/ajtmh.2001.65.193","article-title":"Resistance to treatment in kala-azar: speciation of isolates from northeast India","volume":"65","author":"Sundar","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0180","series-title":"Guia Terap\u00eautico Veterin\u00e1rio","author":"Viana","year":"2007"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0185","first-page":"76","article-title":"Perfil bioqu\u00edmico dos animais de laborat\u00f3rio do Biot\u00e9rio da Faculdade de Medicina da USP","volume":"1","author":"Spinelli","year":"2012","journal-title":"RESBCAL"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0190","series-title":"The laboratory rabbit, guinea pig, hamster, and other rodents","author":"Suckow","year":"2012"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0195","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1515\/BC.2007.061","article-title":"Clinical chemistry reference database for Wistar rats and C57Bl\/6 mice","volume":"388","author":"Boehm","year":"2007","journal-title":"Biol Chem"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0200","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.etp.2010.10.008","article-title":"Cytotoxicity effects of amiodarone on cultured cells","volume":"64","author":"Golli-Bennour","year":"2012","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.ijantimicag.2017.06.007_bib0205","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1128\/AAC.01240-13","article-title":"Dronedarone, an amiodarone analog with improved anti-Leishmania mexicana efficacy","volume":"58","author":"Benaim","year":"2014","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917302170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917302170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T15:53:41Z","timestamp":1656863621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857917302170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0924857917302170"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.06.007","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amiodarone and itraconazole improve the activity of pentavalent antimonial in the treatment of experimental cutaneous leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}